|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
EP0102324A3
(de)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipide und Tenside in wässriger Phase
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
US5112596A
(en)
|
1990-04-23 |
1992-05-12 |
Alkermes, Inc. |
Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability
|
|
US5268164A
(en)
|
1990-04-23 |
1993-12-07 |
Alkermes, Inc. |
Increasing blood-brain barrier permeability with permeabilizer peptides
|
|
US5206234A
(en)
|
1990-10-22 |
1993-04-27 |
Merck & Co., Inc. |
Benzolactam analogs as antagonists of cck
|
|
AU677216B2
(en)
|
1992-07-27 |
1997-04-17 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Targeting of liposomes to the blood-brain barrier
|
|
JP4094066B2
(ja)
|
1996-12-06 |
2008-06-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
インターロイキン−1β変換酵素のインヒビター
|
|
US6514221B2
(en)
|
2000-07-27 |
2003-02-04 |
Brigham And Women's Hospital, Inc. |
Blood-brain barrier opening
|
|
AU2001286930A1
(en)
|
2000-08-30 |
2002-03-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
GB0021831D0
(en)
|
2000-09-06 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
|
US7034036B2
(en)
|
2000-10-30 |
2006-04-25 |
Pain Therapeutics, Inc. |
Inhibitors of ABC drug transporters at the blood-brain barrier
|
|
DE10121982B4
(de)
|
2001-05-05 |
2008-01-24 |
Lts Lohmann Therapie-Systeme Ag |
Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung
|
|
CA2450073C
(en)
|
2001-07-25 |
2017-08-29 |
Biomarin Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
|
AU2002359476A1
(en)
|
2001-11-26 |
2003-06-10 |
Exelixis, Inc. |
MAP4Ks AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
|
|
US20030162695A1
(en)
|
2002-02-27 |
2003-08-28 |
Schatzberg Alan F. |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
|
EP1627043A4
(en)
|
2002-10-23 |
2006-10-11 |
Exelixis Inc |
MAPK7 AS A BRANCHING METHOD AND MODIFYING METHOD
|
|
JP4995423B2
(ja)
|
2002-12-03 |
2012-08-08 |
ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート |
物質を血液−脳関門を渡って輸送するための人工低密度リポタンパク質キャリア
|
|
WO2005025511A2
(en)
|
2003-09-10 |
2005-03-24 |
Cedars-Sinai Medical Center |
Potassium channel mediated delivery of agents through the blood-brain barrier
|
|
US7390798B2
(en)
|
2004-09-13 |
2008-06-24 |
Merck & Co., Inc. |
Carboxamide spirolactam CGRP receptor antagonists
|
|
CN101346395A
(zh)
|
2005-12-30 |
2009-01-14 |
默克专利有限公司 |
阻止复合有IL-6Rα的IL-6与GP130结合的抗IL-6抗体
|
|
JP5511379B2
(ja)
|
2006-07-21 |
2014-06-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Cgrpレセプターアンタゴニスト
|
|
CA2722418C
(en)
|
2008-05-13 |
2013-09-17 |
Irm Llc |
Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
|
|
EP2773341A2
(en)
|
2011-10-21 |
2014-09-10 |
Massachusetts Eye & Ear Infirmary |
Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
|
|
JP6267193B2
(ja)
|
2012-05-22 |
2018-01-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
置換ジピリジルアミン類及びそれらの使用
|
|
MX2015000362A
(es)
|
2012-07-13 |
2015-04-14 |
Hoffmann La Roche |
Benzo(b)-azepin-2-onas antiproliferativas.
|
|
RU2015105561A
(ru)
|
2012-08-09 |
2016-09-27 |
Ф. Хоффманн-Ля Рош Аг |
Замещенные гетероазепиноны
|
|
MX2015009270A
(es)
|
2013-01-18 |
2015-10-30 |
Hoffmann La Roche |
Pirazoles sustituidos en posicion 3 y uso de los mismos como inhibidores de la cinasa cremallera de leucinas dual (dlk).
|
|
TWI648274B
(zh)
|
2013-02-15 |
2019-01-21 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺類 (二)
|
|
WO2014145022A1
(en)
|
2013-03-15 |
2014-09-18 |
President And Fellows Of Harvard College |
Hybrid necroptosis inhibitors
|
|
EP2986317A4
(en)
|
2013-04-15 |
2016-10-05 |
Yeda Res & Dev |
INHIBITION OF RIP KINASES FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES
|
|
TWI710558B
(zh)
|
2013-05-01 |
2020-11-21 |
瑞士商赫孚孟拉羅股份公司 |
二雜芳基化合物及其用途
|
|
RU2015147601A
(ru)
|
2013-05-01 |
2017-06-05 |
Ф. Хоффманн-Ля Рош Аг |
С-связанные гетероциклоалкилзамещенные пиримидины и их применения
|
|
MX2016008110A
(es)
|
2013-12-20 |
2016-08-19 |
Hoffmann La Roche |
Derivados de pirazol como inhibidores de la cinasa de cremallera de leucina dual (dlk) y usos de los mismos.
|
|
RU2017109122A
(ru)
|
2014-08-21 |
2018-09-21 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Способы лечения с использованием гетероциклических амидов в качестве ингибиторов киназы
|
|
JP6701225B2
(ja)
|
2015-03-09 |
2020-05-27 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
三環式dlk阻害剤及びその使用
|
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
|
RU2716136C2
(ru)
*
|
2015-07-02 |
2020-03-06 |
Ф. Хоффманн-Ля Рош Аг |
Бициклические лактамы и способы их применения
|
|
MD3316969T2
(ro)
|
2015-07-02 |
2022-07-31 |
Janssen Sciences Ireland Unlimited Co |
Compuși antibacterieni
|
|
CN111909173B
(zh)
|
2015-07-02 |
2025-03-04 |
豪夫迈·罗氏有限公司 |
苯并氧氮杂䓬噁唑烷酮化合物及其使用方法
|
|
KR20170004814A
(ko)
|
2015-07-02 |
2017-01-11 |
주식회사 녹십자 |
헌터증후군 치료제
|
|
CN108602809B
(zh)
|
2015-12-04 |
2022-09-30 |
戴纳立制药公司 |
异噁唑烷衍生的受体相互作用蛋白激酶1(ripk 1)的抑制剂
|
|
AU2016370779B2
(en)
*
|
2015-12-17 |
2019-07-25 |
Astex Therapeutics Limited |
Quinoline-3-carboxamides as H-PGDS inhibitors
|
|
US10961258B2
(en)
|
2015-12-21 |
2021-03-30 |
Glaxosmithkline Intellectual Property Development Limited |
Heterocyclic amides as kinase inhibitors
|
|
EP3394072A4
(en)
|
2015-12-23 |
2019-05-29 |
President and Fellows of Harvard College |
Cortistatin analogs and uses thereof
|
|
US9815850B2
(en)
|
2016-02-05 |
2017-11-14 |
Denali Therapeutics Inc. |
Compounds, compositions and methods
|
|
JP7349359B2
(ja)
|
2016-10-17 |
2023-09-22 |
エフ. ホフマン-ラ ロシュ アーゲー |
二環式ピリドンラクタム及びその使用方法。
|
|
US11072607B2
(en)
*
|
2016-12-16 |
2021-07-27 |
Genentech, Inc. |
Inhibitors of RIP1 kinase and methods of use thereof
|